Evidence map›Paper›PMID 30301901›Full record

ArticleScientific reports2018

A Pre-Clinical Large Animal Model of Sustained Liver Injury and Regeneration Stimulus.

Kenta Inomata, Kazuki Tajima, Hiroshi Yagi, Hisanobu Higashi, Hirofumi Shimoda, Kentaro Matsubara, Taizo Hibi, Yuta Abe, Hanako Tsujikawa, Minoru Kitago and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Kenta InomataDepartment of Surgery, Keio University, Tokyo, Japan.
Kazuki TajimaDepartment of Surgery, Keio University, Tokyo, Japan.
Hiroshi YagiDepartment of Surgery, Keio University, Tokyo, Japan. h_yagi@a3.keio.jp.
Hisanobu HigashiDepartment of Surgery, Keio University, Tokyo, Japan.
Hirofumi ShimodaDepartment of Surgery, Keio University, Tokyo, Japan.
Kentaro MatsubaraDepartment of Surgery, Keio University, Tokyo, Japan.
Taizo HibiDepartment of Surgery, Keio University, Tokyo, Japan.
Yuta AbeDepartment of Surgery, Keio University, Tokyo, Japan.
Hanako TsujikawaDepartment of Pathology, Keio University, Tokyo, Japan.
Minoru KitagoDepartment of Surgery, Keio University, Tokyo, Japan.
Masahiro ShinodaDepartment of Surgery, Keio University, Tokyo, Japan.
Hideaki ObaraDepartment of Surgery, Keio University, Tokyo, Japan.
Osamu ItanoDepartment of Surgery, Keio University, Tokyo, Japan.
Alejandro Soto-GutierrezDepartment of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Yuko KitagawaDepartment of Surgery, Keio University, Tokyo, Japan.
Keio University · JPUniversity of Pittsburgh · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A feasible large animal model to evaluate regenerative medicine techniques is vital for developing clinical applications. One such appropriate model could be to use retrorsine (RS) together with partial hepatectomy (PH). Here, we have developed the first porcine model using RS and PH. RS or saline control was administered intraperitoneally to Göttingen miniature pigs twice, two weeks apart. Four weeks after the second dose, animals underwent PH. Initially, we tested different doses of RS and resection of different amounts of liver, and selected 50 mg/kg RS with 60% hepatectomy as our model for further testing. Treated animals were sacrificed 3, 10, 17 or 28 days after PH. Blood samples and resected liver were collected. Serum and liver RS content was determined by Liquid Chromatograph-tandem Mass Spectrometer. Blood analyses demonstrated liver dysfunction after PH. Liver regeneration was significantly inhibited 10 and 17 days after PH in RS-treated animals, to the extent of 20%. Histological examination indicated hepatic injury and regenerative responses after PH. Immunohistochemical staining demonstrated accumulation of Cyclin D1 and suppression of Ki-67 and PCNA in RS-treated animals. We report the development of the first large animal model of sustained liver injury with suppression of hepatic regeneration.

Indexed as

Regenerative MedicineAnimalsCyclin D1Disease Models, AnimalDose-Response Relationship, DrugHepatectomyHepatocytesKi-67 AntigenLiverLiver RegenerationPyrrolizidine AlkaloidsSwineSwine, MiniatureCyclin D1Ki-67 AntigenPyrrolizidine Alkaloidsretrorsine

Identifiers

PMID30301901
PMCPMC6177392
OpenAlexW2895427826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.